BRIEF published on 04/21/2026 at 07:35, 22 days 21 hours ago Sensorion prépare son Assemblée Générale annuelle Actionnaires Assemblée Générale Documents Préparatoires Vote À Distance Sensorion
BRIEF published on 04/21/2026 at 07:35, 22 days 21 hours ago Sensorion is preparing for its Annual General Meeting Shareholders General Assembly Preparatory Documents Remote Voting Sensory
PRESS RELEASE published on 04/21/2026 at 07:30, 22 days 21 hours ago Terms of availability of the preparatory documents for the GM Sensorion provides Preliminary Documents for the Combined Shareholders' General Meeting of May 11, 2026. Shareholders urged to participate in a critical meeting addressing new therapies for hearing loss disorders Biotechnology Shareholders' Meeting Gene Therapy Sensorion Hearing Loss
PRESS RELEASE published on 04/21/2026 at 07:30, 22 days 21 hours ago Modalités de mise à disposition des documents préparatoires à l'AG Sensorion annonce la mise à disposition des documents préparatoires à l'Assemblée Générale mixte du 11 mai 2026. Les actionnaires peuvent voter à distance. Contact: contact@sensorion-pharma.com Actionnaires Documents Préparatoires Assemblée Générale Mixte Vote À Distance Sensorion
BRIEF published on 03/23/2026 at 07:35, 1 month 21 days ago Sensorion Updates on Audiogene Trial and Advances GJB2-GT Clinical Trials Gene Therapy Sensorion Hearing Loss SENS-601
BRIEF published on 03/23/2026 at 07:35, 1 month 21 days ago Sensorion poursuit son développement en thérapie génique pour la surdité Thérapie Génique SENS-501 Surdité Congénitale Audiogene SENS-601
BRIEF published on 03/23/2026 at 07:35, 1 month 21 days ago Sensorion continues its development in gene therapy for deafness Gene Therapy Congenital Deafness Audiogene Sense-501 Sense-601
BRIEF published on 03/23/2026 at 07:35, 1 month 21 days ago Mises à jour de Sensorion sur l'essai Audiogene et les progrès du GJB2-GT Essais Cliniques Thérapie Génique Sensorion Perte Auditive SENS-601
PRESS RELEASE published on 03/23/2026 at 07:30, 1 month 21 days ago Informations privilégiées / Autres communiqués Sensorion publie les données à six mois de l’essai clinique de Phase 1/2 Audiogene pour SENS-501 et poursuit le développement clinique du GJB2-GT (SENS-601) vers une première administration chez l’homme Essai Clinique Thérapie Génique Sensorion Surdité GJB2-GT
BRIEF published on 03/18/2026 at 07:35, 1 month 26 days ago Sensorion publie ses résultats 2025 et les dernières nouvelles de l'entreprise Résultats Financiers Thérapie Génique Sensorion Perte Auditive Investissements Sanofi
Published on 05/14/2026 at 04:15, 30 minutes ago Battery X Metals Announces Corporate Awareness Engagement
Published on 05/14/2026 at 03:15, 1 hour 30 minutes ago Jaguar Delivers Strong Adjusted Earnings and Strategic Production Restart of MTL (Turmalina Mine) in Q1 2026
Published on 05/13/2026 at 23:30, 5 hours 15 minutes ago CCL Industries Announces Results for 2026 First Quarter
Published on 05/14/2026 at 03:20, 1 hour 25 minutes ago TCL Electronics (01070.HK) Maintains Strong Growth in Q1 2026
Published on 05/14/2026 at 01:05, 3 hours 40 minutes ago THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 22:20, 6 hours 24 minutes ago Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:18, 8 hours 26 minutes ago EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 18:02, 10 hours 43 minutes ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 10 hours 45 minutes ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
Published on 05/13/2026 at 17:45, 11 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
